Atlas Trials

Clinical Study of TA-650 in Patients With Refractory Kawasaki Disease

Clinical trial NCT01596335 · COMPLETED

Trial details

NCT number
NCT01596335
Sponsor
Tanabe Pharma Corporation
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Kawasaki Disease Refractory to Initial Therapy With Intravenous Immunoglobulin
Start date
2012-05-01
Primary completion
2014-10-01
Enrollment
31

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.